Downregulation of SETD5 Suppresses the Tumorigenicity of Hepatocellular Carcinoma Cells (KAP220167)
In this study, we demonstrated that SETD5 expression is positively associated with poor prognosis of HCC and that SETD5 depletion decreased the proliferation and invasion of HCC cells while inducing cell death. Transcriptome analysis revealed that SETD5 loss downregulated the interferon-mediated inflammatory response in HCC cells